Algernon Pharmaceuticals Inc. (CSE: AGN) (OTCQB: AGNPF) Starts Presentation at The LD 500
Algernon Pharmaceuticals Inc. (CSE: AGN) (OTCQB: AGNPF) is a clinical-stage pharmaceutical development company that investigates safe, already approved drugs for new disease applications. Algernon is a drug re-purposing company focused on moving these drugs efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off-label prescription writing. Algernon has filed new intellectual property rights globally for NP-120 (Ifenprodil) for the treatment of respiratory diseases such as COVID-19 and is working to develop a proprietary injectable and…







